Table 5. DFS and OS of esophageal squamous cell carcinoma patients with elevations and no elevations in pretreatment serum LDL-C according to their LHR.
| LHR | p value | |||
|---|---|---|---|---|
| <2.12 | ≥2.12 | |||
| Patients with elevations in LDL-C | ||||
| Patients, n (%) | 17 (25.4%) | 50 (74.6%) | ||
| DFS Median (range) |
29.0 (6.0-69.6) | 59.7 (1.5-71.0) | 0.071 | |
| OS Median (range) |
40.2 (12.0-69.9) | 61.4 (3.5-71.0) | 0.065 | |
| Patients with no elevations in LDL-C | ||||
| Patients, n (%) | 92 (61.5%) | 55 (38.5%) | ||
| DFS Median (range) |
17.2 (1.3-69.6) | 29.4 (1.3-69.4) | 0.036* | |
| OS Median (range) |
24.2 (3.0-69.9) | 47.5 (1.3-69.4) | 0.044* |
Abbreviations: LDL-C: low-density lipoprotein cholesterol LHR: LDL-C/HDL-C ratio
DFS: disease-free survival OS: overall survival